Fedratinib Completed Phase 1 Trials for Neoplasms Malignant Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01836705Effect of SAR302503 on ECG Activity in Patients With Solid Tumors